Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Cash from Operations (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Cash from Operations for 17 consecutive years, with 6932000.0 as the latest value for Q1 2026.

  • Quarterly Cash from Operations rose 37.48% to 6932000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 45344000.0 through Mar 2026, down 27.48% year-over-year, with the annual reading at 49500000.0 for FY2025, 66.27% down from the prior year.
  • Cash from Operations for Q1 2026 was 6932000.0 at Achieve Life Sciences, up from 18000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 4364000.0 in Q4 2023, with the low at 18000000.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 8720588.24, with a median of 8340000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations plummeted 113.55% in 2022, then soared 60.84% in 2023.
  • Achieve Life Sciences' Cash from Operations stood at 11143000.0 in 2022, then soared by 60.84% to 4364000.0 in 2023, then crashed by 110.56% to 9189000.0 in 2024, then plummeted by 95.89% to 18000000.0 in 2025, then skyrocketed by 61.49% to 6932000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Cash from Operations are 6932000.0 (Q1 2026), 18000000.0 (Q4 2025), and 11343000.0 (Q3 2025).